GNCA Genocea Biosciences, Inc.

6.86
0  -3%
Previous Close 7.10
Open 7.10
Price To book 4.43
Market Cap 195.13M
Shares 28,444,000
Volume 461,138
Short Ratio 14.96
Av. Daily Volume 210,900

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Topline data did not meet endpoints - September 2015
GEN-004
Universal vaccine candidate against pneumococcus
Phase 2b data released January 6, 2017. 12-month data due 2H 2017. Phase 3 to commence 4Q 2017.
GEN-003
Genital herpes